ZOCOR Drug Patent Profile
✉ Email this page to a colleague
When do Zocor patents expire, and what generic alternatives are available?
Zocor is a drug marketed by Organon and is included in one NDA.
The generic ingredient in ZOCOR is simvastatin. There are forty drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the simvastatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zocor
A generic version of ZOCOR was approved as simvastatin by AUROBINDO PHARMA on December 20th, 2006.
Summary for ZOCOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 113 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZOCOR |
What excipients (inactive ingredients) are in ZOCOR? | ZOCOR excipients list |
DailyMed Link: | ZOCOR at DailyMed |
Pharmacology for ZOCOR
Drug Class | HMG-CoA Reductase Inhibitor |
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ZOCOR
US Patents and Regulatory Information for ZOCOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-001 | Dec 23, 1991 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-004 | Dec 23, 1991 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-002 | Dec 23, 1991 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-003 | Dec 23, 1991 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOCOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-001 | Dec 23, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-002 | Dec 23, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-002 | Dec 23, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ZOCOR | simvastatin | TABLET;ORAL | 019766-001 | Dec 23, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZOCOR
See the table below for patents covering ZOCOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1404 | 6(R)-(2-(8'-ACYLOXY-2'-METHYL-6'-METHYL (OR HYDROGEN)-POLYHYDRONAPHTHYL-1')-ETHYL)-4(R)-HYDROXY-3,4,5,6-TETRAHYDRO-2H-PYRAN-2-ONES, THE HYDROXY ACID FORM OF SAID PYRANONES, THE PHARMACEUTICALLY ACCEPTABLE SALTS OF SAID HYDROXY ACIDS, AND THE LOWER ALKYL, AND PHENYL, DIMETHYLAMINO OR ACETYLAMINO SUBSTITUTED LOWER ALKYL ESTERS OF SAID HYDROXY ACID, PROCESSES FOR PREPARING THE SAME, AND A PHARMACEUTICAL ANTIHYPERCHOLESTEROLEMIC COMPOSITION CONTAINING THE SAME | ⤷ Try a Trial |
Latvia | 5249 | Piranonu iegusanas metode | ⤷ Try a Trial |
Canada | 1340331 | INHIBITEURS DE LA REDUCTASE HMG-COA (HMG-COA REDUCTASE INHIBITORS) | ⤷ Try a Trial |
Malaysia | 8700745 | 6(R)-(2-8-ACYLOXY-2'-METHYL-6'METHYL(OR HYDROGEN)-POLYHYDRONAPTHYL-1')-ETHYL)-4(R)-HYDROXY-3,4,5,6-TETRAHYDRO-24-PYRAN-2-ONES, THE HYDROXY ACID FROM OF SAID PYRANONES, THE PARMACEUTICALLY ACCEPTABLE SATLS OF SAID HYDROXY ACIDS, AND THE LOWER ALKYL, AND PHENYL, DIMETHYLAMINO OR ACETYLAMINO SUBSTITUTED LOWER ALKYL ESTERS OF SAID HYDROXY ACID, PROCESSES FOR PREPARING THE SAME, AND A PARMACEUTICAL ANTIHYPERCHOLESTEROLEMIC COMPOSITION CONTAINING THE SAME. | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZOCOR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0033538 | SPC/GB93/005 | United Kingdom | ⤷ Try a Trial | |
0720599 | 122004000026 | Germany | ⤷ Try a Trial | PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 58866.00.00 58866.01.00 58866.02.00 58866.03.00 58870.00.00 58870.01.00 58870.02.00 58870.03.00 58874.00.00 58874.01.00 58874.02.00 58874.03.00 58878.00.00 58878.01.00 58878.02.00 58878.03.00 20040402 FIRST REGISTRATION: DE 58866.00.00 - 58866.03.00 58870.00.00 - 58870.03.00 58874.00.00 - 58874.03.00 58878.00.00 - 58878.03.00 20040402 |
0720599 | SPC/GB05/010 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: EZETIMIBE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN COMBINATION WITH SIMVASTATIN; REGISTERED: DE 58874.00.00 20040402; DE 58874.01.00 20040402; DE 58874.02.00 20040402; DE 58874.03.00 20040402; DE 58878.00.00 20040402; DE 58878.01.00 20040402; DE 58878.02.00 20040402; DE 58878.03.00 20040402; DE 58866.00.00 20040402; DE 58866.01.00 20040402; DE 58866.02.00 20040402; DE 58866.03.00 20040402; DE 58870.00.00 20040402; DE 58870.01.00 20040402; DE 58870.02.00 20040402; DE 58870.03.00 20040402; UK PL 19945/0003 20041118; UK PL 19945/0004 20041118; UK PL 19945/0005 20041118; UK PL 19945/0006 20041118; UK PL 19945/0007 20041118; UK PL 19945/0008 20041118; UK PL 19945/0009 200411 |
0720599 | 26/2005 | Austria | ⤷ Try a Trial | PRODUCT NAME: EZETIMIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON KOMBINIERT MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 1-25673 - 1-25676 20041228; FIRST REGISTRATION: DE 58874.00.00 - 58874.03.00; 58878.00.00 - 20040402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |